Peptides Weight Loss
HGH Fragment 176-191 (AOD-9604)
AOD-9604 · HGH Frag · AOD9604 · Fragment 176-191
Modified fragment of the growth hormone C-terminus studied for lipolysis without growth effects.
🚧 Expanded guide coming soon. This compound has PK data and a source — a full overview, mechanism, and dosing guide is pending editorial review.
Pharmacokinetic summary
- Model tier
- Simple (t½ + F, Tmax estimated)
- Half-life
- 0.5 days
- Bioavailability
- 50%
- Typical dose
- 0.25–1 mg
Related compounds
Semaglutide Injection (Ozempic/Wegovy)
Long-acting GLP-1 receptor agonist for type 2 diabetes and weight loss; weekly injection.
Semaglutide Oral (Rybelsus)
Oral semaglutide with very low bioavailability; taken fasting.
Tirzepatide (Mounjaro)
Dual GIP/GLP-1 agonist for weight loss and diabetes; weekly injection, strong efficacy.
Protocols featuring HGH Fragment 176-191 (AOD-9604)
Comments
Loading comments…